Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC

Summary by AI BETAClose X

Barclays disclosed on 13 Nov 2026 that as at 12 Nov 2026 it held 8,683,746 long exposures (3.93%) and 8,684,381 short exposures (3.93%) in Advanced Medical Solutions Group plc 5p ordinary shares, comprising 7,798,969 directly owned shares (3.53%) and cash-settled derivatives of 884,777 (0.40%); intra-day trades included purchases totaling 469,206 shares (430,338 at £2.830, 23,000 at £2.835, 15,868 at £2.825) and sales of 344,439 shares (328,571 at £2.830, 15,868 at £2.825), alongside multiple swaps and CFDs that adjusted short and long exposures.

Disclaimer*

UK 100

Latest directors dealings